We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002241:SZSEGoertek Inc. Analysis

Data as of 2026-06-12 - not real-time

CN¥23.01

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Goertek’s price is trading below its short‑ and medium‑term moving averages, indicating a lagging momentum. The MACD histogram remains in negative territory, reinforcing a bearish technical bias. RSI sits in the low‑to‑mid range, suggesting limited upside momentum but not yet oversold. Volume has been on a downtrend, which could constrain short‑term price rallies. Despite these signals, the stock offers an high dividend yield that ranks among the higher tiers in its sector. The current market price is marginally above the discounted cash flow estimate, placing valuation in a fair range.
Revenue growth remains robust, driven by expanding demand for smart wearables and AR/VR components. Operating margins are modest, yet the company maintains a strong cash position that more than offsets its debt load. Free cash flow is negative, but operating cash flow stays positive, supporting ongoing dividend payouts. The payout ratio is comfortably low, indicating that the dividend is sustainable over the coming years. Analyst consensus leans toward an buy recommendation with price targets well above today’s level. Combined with sector tailwinds and a solid balance sheet, the stock presents an attractive risk‑adjusted opportunity for medium‑ to long‑term investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near support level
  • negative MACD histogram
  • attractive dividend yield

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • solid revenue growth
  • valuation advantage versus industry peers
  • analyst price targets indicating upside

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • exposure to high‑growth AR/VR market
  • sustainable dividend policy
  • strong cash balance supporting future investments

Key Metrics & Analysis

Financial Health

Revenue Growth14.40%
Profit Margin4.02%
P/E Ratio20.2
ROE10.77%
ROA1.73%
Debt/Equity63.58
P/B Ratio2.2
Op. Cash FlowCN¥4.7B
Free Cash FlowCN¥-3092786432
Industry P/E36.8

Technical Analysis

TrendNeutral
RSI37.8
SupportCN¥22.25
ResistanceCN¥29.18
MA 20CN¥25.43
MA 50CN¥24.78
MA 200CN¥28.33
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair ValueCN¥22.76
Target PriceCN¥31.90
Upside/Downside38.64%
GradeFair
TypeBlend
Dividend Yield3.48%

Risk Assessment

Beta0.55
Volatility49.35%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.